Merck KGaA, Darmstadt, Germany, Establishes External Expert Committee for Sustainability
- Six international experts advise the company on sustainability issues
- Committee is part of the sustainability strategy of Merck KGaA, Darmstadt, Germany
- Sustainability committee supplements the existing expert panels on bioethics and digital ethics
Darmstadt, Germany, November 2, 2021 – Merck KGaA, Darmstadt, Germany, a leading science and technology company, has established an external expert committee for sustainability. The Sustainability Advisory Panel of Merck KGaA, Darmstadt, Germany, consists of six independent international experts on sustainability-related topics. They will advise the company on selected issues and critically assess its sustainability performance as well as the company’s planned activities. Moreover, they apply their knowledge to help address societal and political challenges and developments that could impact the businesses of Merck KGaA, Darmstadt, Germany.
“As a science and technology company, we want to find answers to the most pressing challenges of our time. That’s why we have embedded sustainability as a key element of our corporate strategy and set ourselves ambitious goals. The internationally renowned experts of the Sustainability Advisory Panel of Merck KGaA, Darmstadt, Germany, will support us in achieving these goals,” said Herwig Buchholz, Head of Group Corporate Sustainability, who chairs the Sustainability Advisory Panel for Merck KGaA, Darmstadt, Germany.
The Sustainability Advisory Panel of Merck KGaA, Darmstadt, Germany, consists of the following members:
- Glynda Bathan-Baterina (Philippines): Deputy Executive Director of Clean Air Asia
- Michael Braungart (Germany): Founder and CEO of Braungart EPEA Internationale Umweltforschung, Professor at Leuphana University Lüneburg
- Todd Cort (United States): Faculty Co-Director of both the Center for Business and Environment (CBEY) and the Initiative on Sustainable Finance (YISF) of the Yale School of Management
- Maja Göpel (Germany): Expert for sustainability policies and transformation research, Honorary Professor at Leuphana University Lüneburg
- Ioannis Ioannou (United Kingdom): Associate Professor for strategy and entrepreneurship at the London Business School
- Huiyao (Henry) Wang (China): Founder and President of Center for China and Globalization (CCG)
The specialist knowledge of these experts covers a broad range of topics: From shaping and implementing ideas for environmental and climate protection to entrepreneurial sustainability principles, future-oriented business and international trade, sustainable leadership, and sustainability transformation as well as ESG key figures and sustainable finance.
Merck KGaA, Darmstadt, Germany, presented its sustainability strategy in November 2020. With this strategy, the company is pursuing specific goals in the areas of science and technology and value chains as well as climate change and the environment:
- Goal 1: In 2030, Merck KGaA, Darmstadt, Germany, will achieve human progress for more than one billion people through sustainable science and technology.
- Goal 2: By 2030, the company will integrate sustainability into all its value chains.
- Goal 3: By 2040, Merck KGaA, Darmstadt, Germany, will achieve climate neutrality and reduce its resource consumption.
Merck KGaA, Darmstadt, Germany, also wants to make a clearly recognizable contribution to the Sustainable Development Goals of the United Nations. Over the past several months, the company has made clear progress in the implementation. For example, the most recent Annual General Meeting agreed to a resolution to integrate sustainability aspects into the compensation system of the Executive Board. The company is working to systematically incorporate sustainability into all company processes.
Independent advisory panels have been supporting Merck KGaA, Darmstadt, Germany, in answering ethical questions for more than 10 years: The Ethics Advisory Panel of Merck KGaA, Darmstadt, Germany, which was established in 2011, and the company’s Digital Ethics Advisory Panel which was founded in early 2021. The Ethics Advisory Panel provides orientation regarding (bio-)ethical questions arising from the business and from the company’s research. Thanks to its work, over the past decade, Merck KGaA, Darmstadt, Germany, has positioned itself as an industry leader in applying bioethical principles to the evaluation of products and services of its business sectors. In view of the ever-increasing emergence of digital business models and applications in the healthcare industry and other industrial sectors, the Digital Ethics Advisory Panel of Merck KGaA, Darmstadt, Germany, advises the company especially on the rapidly developing field of digital ethics.
You can find more on the topic of sustainability at Merck KGaA, Darmstadt, Germany, at: www.emdgroup.com/en/sustainability
All Merck KGaA, Darmstadt, Germany, press releases are distributed by e-mail at the same time they become available on the EMD Group Website. In case you are a resident of the USA or Canada please go to www.emdgroup.com/subscribe to register for your online subscription of this service as our geo-targeting requires new links in the email. You may later change your selection or discontinue this service.
About Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and electronics. Around 58,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2020, Merck KGaA, Darmstadt, Germany, generated sales of € 17.5 billion in 66 countries.
The company holds the global rights to the name and trademark “Merck” internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Electronics. Since its founding in 1668, scientific exploration and responsible entrepreneurship have been key to the company’s technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company.
Merck KGaA, Darmstadt, Germany, has acquired Massachusetts-based Erbi Biosystems, a developer of the 2 ml micro-bioreactor platform technology, known as the “Breez™”.